VCL

Vaxtex Cotfab Limited

Listed company · ISIN INE098201036 · NSE BE · FV ₹1
Last price
₹2
+1.21%today
What this company does

Vaxtex Cotfab Limited is a listed company. It booked ₹0 cr of revenue in its latest quarter (Q1 FY27).

In the report:
41out of 100
Equitytale Health Score
Strained

Healthier than 41% of listed companies we score, on all six measures of filed financials. Each measure is ranked against the 1,201–2,858 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
50

At close. Not part of the score.

Profitability & returns9

How much profit it earns on the money it employs

Balance sheet41

How much it owes, and whether earnings cover the interest

Cash quality35

Whether reported profit actually arrives as cash

Growth & consistency52

Whether sales and profit have grown, and how steadily

Valuation70

What today's price implies, against our models or its peers

Governance & risk72

How much of the promoters' stake is pledged, and how much they hold

Is this company doing well?
not investment advice
Some things to watch
Strengths
No promoter shares pledged
Watch-outs
! Currently loss-making
! Low -0.9% return on equity
! Operating cash flow is negative

What if I invest in VCL?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹2 +1.21%
latest close · 2026-09-17
52-wk low ₹142 sessions so far52-wk high ₹2
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/B ratio1.37Moderate
Below bookModerateHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity-0.9%Loss
WeakFairStrong ▸15%
Return on capital-1.0%Loss
WeakFairStrong
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.23Comfortable
LowModerateHigh ▸1
Interest cover-8.7×Risky
RiskyOkayStrong ▸5×
Current ratio2.84Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹31 cr
Book value
₹1
EPS
₹0.00
latest quarter
Net debt
₹5 cr
owes more than its cash
Enterprise value
₹36 cr
EBITDA
₹-24.8 L
annualised
EBIT
₹-24.8 L
annualised
Operating margin
Return on assets
-0.6%
Earnings yield
P/S
Sales / share
₹0.0
Tax rate
Face value
₹1
Shares
18.4 cr
Working capital
₹23 cr
Current assets
₹36 cr
Current liabilities
₹13 cr
Delivery %
89.1%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2024 report & filings
not investment advice
Hard to value confidentlyLow confidence
One year's profit is a one-off (far above the multi-year norm), so its recurring earnings power is unclear.
Models span ₹0₹1, midpoint ₹1

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹0 cr
Other Income₹2.4 L
Total Income₹2.4 L
Cost of Materials₹0 cr
Purchases of Stock-in-Trade₹0 cr
Employee Benefit Expense₹3.4 L
Finance Costs₹0.71 L
Depreciation & Amortisation₹0 cr
Other Expenses₹5.2 L
Total Expenses₹9.3 L
Profit before Tax₹-6.9 L
Tax Expense₹-1.7 L
Net Profit₹-5.2 L
Net margin on total income-217.7%
Where the money goes · Q1 FY27
% of total spend
Employee benefit expense₹3.4 L36.4%
Finance costs₹0.71 L7.7%
Other expenses₹5.2 L56.0%
Total income ₹2.4 L

The company made a net loss of ₹5.2 L this quarter — income covered only 26 of every ₹100 it spent on costs and tax.

Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue9 cr0 cr0 cr
Total income10 cr49.8 L2.4 L
Expenses7 cr10.3 L9.3 L
Profit before tax4 cr39.5 L-6.9 L
Tax-9.4 L-39.4 L-1.7 L
Net profit (owners' share)4 cr78.9 L-5.2 L
Net margin (owners' share, on revenue)44.4%
EPS (₹)0.220.040.00
YoY (latest quarter): total income -94.9% · net profit
Balance sheet & cash flow · as of Mar 2026
Low debt
Total assets
₹37 cr
Shareholder equity
₹22 cr
parent shareholders
Total debt
₹5 cr
Cash
₹5.1 L
Cash flow · H1 FY26
Operating
₹-2 cr
Investing
₹2 cr
Financing
₹-21.7 L
Who owns it · 2026-06-30
No pledge
Promoter
0.5%
FII / Foreign
11.1%
DII / Domestic
Retail / others
88.4%
Promoter stake down 17.6% over the last 12 quarters.
Smart-money activity
Insider trades
BoughtVaxfab Enterprises Limited · Other2.59 cr · ₹12.0 cr20 Feb 23
SoldVAX ENTERPRISE PRIVATE LIMITED (Formerly known as Miracle Stores Private Limited) · Promoters34.13 L · ₹715 Feb 23
SoldVAX ENTERPRISE PRIVATE LIMITED (Formerly known as Miracle Stores Private Limited) · Promoters10.00 L · ₹73.0 L7 Dec 22
Bulk / block deals
BoughtZEAL GLOBAL OPPORTUNITIES FUND · NSE42.79 L @ ₹1.615 Sep 26
BoughtZEAL GLOBAL OPPORTUNITIES FUND · NSE26.00 L @ ₹1.5715 Sep 26
SoldRAJVANSH ELECTRICALS PRIVATE LIMITED · NSE9.40 L @ ₹1.6515 Sep 26
Stake changes
BoughtNOVA GLOBAL OPPORTUNITIES FUND PCC→ 6.05% · 19.91 L6 Jan 26
SoldQmin Industries Limited · promoter→ 0.21% · 2.02 cr2 Dec 25
SoldVax Enterpirses Pvt Ltd · promoter→ 0.00% · 84.94 L17 Nov 25
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Special shareholder meeting · 27 Feb 2026
See the official result
1
To Approve The Increase in Authorised Share Capital of the Compan
Backed by 100% of shareholders other than promotersneeded 50%
1.93 cr votes for, 7 against · 0% of mutual funds and other big investors said no
2
To alter the existing object clause of Memorandum of Association (“MOA”) of the Company.
Backed by 100% of shareholders other than promotersneeded 75%
1.92 cr votes for, 7 against · 0% of mutual funds and other big investors said no
3
To Change the name and other clauses of Memorandum and Articles of Association of the Company.
Backed by 99% of shareholders other than promotersneeded 75%
1.92 cr votes for, 1.00 L against · 0% of mutual funds and other big investors said no
4
Increasing the Borrowing Powers under Section 180(1)(C) of the Companies Act, 2013.
Backed by 99% of shareholders other than promotersneeded 75%
1.92 cr votes for, 1.00 L against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 5 named members
owning 0.5% between them · as of 2026-06-30
BHARTI KAILASH GUPTA0.40%
KHUSHANT GUPTA0.10%
MITHLESHKUMAR M AGRAWALno shares
Qmin Industries Limitedno shares
Vax Enterprise Private Limitedno shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.